-
Australian Researchers Have Discovered Trick For Earlier Mesothelioma Diagnosis
Malignant mesothelioma is an extremely challenging condition for patients and physicians alike. The disease, which is caused by exposure to asbestos, is always considered fatal: it is highly resistant to standard cancer treatments and is often not diagnosed until it is in an advanced stage within the body. With these factors driving them, researchers around
-
Mesothelioma Lawsuit Cites Defects in 3M Respirators’
A mesothelioma lawsuit that was filed in the state of Wisconsin has moved into a new phase as District Judge William M. Conley denied defendant 3M Company’s attempts to have the case against them dropped. At issue are 3M respirators that were distributed to employees at Weyerhaeuser Company’s door manufacturing plant, located in Marshfield Wisconsin.
-
Immunotherapy Drug That Initially Disappointed for Mesothelioma May Get Second Look
Whether you’re talking about malignant mesothelioma or any other form of cancer, all eyes are on immunotherapy as the future of treatment. Immunotherapy drugs have triggered the body’s immune response, countering cancer’s ability to escape the immune system in many types of the disease. Unfortunately, not all immunotherapy drugs work on all types of cancer.
-
Mesothelioma Patients May Benefit From Newly Approved Paxman Cooling Cap
Like so many other patients who have been diagnosed with solid tumors, one of the side effects of treatment that people who have been diagnosed with malignant mesothelioma dread most is the loss of their hair following chemotherapy treatment. Though they may have more pressing and existential issues to address, losing their hair removes their
-
Mesothelioma Advocates View ‘Right to Try Act’ With Caution
In the wake of President Donald J. Trump having signed the “Right to Try Act” into law, mesothelioma patients, their family members and advocates are struggling to assess whether the action represents a step forward or the introduction of greater risk for those facing the terminal form of cancer. The law provides patients diagnosed with
-
Study Reveals Better Outcomes for Mesothelioma Patients at High Volume Facilities
“Practice makes perfect” may seem like a toss away phrase, but when it comes to treating malignant pleural mesothelioma, it turns out that it’s an essential truth, at least according to a new study published in the journal Lung Cancer. A report looking into the results of over 1300 mesothelioma patients in the National Cancer Database
-
Court Corrects Insurer Who Tries to Avoid Paying Mesothelioma Claim
A recent workers’ compensation case heard by the Supreme Court of Missouri illuminates the many challenges of filing a mesothelioma claim, as well as the inherent value of demanding justice and fair treatment. The case involved the family of Robert Casey, a floor tile installer who had worked for several different companies throughout his career.
-
Minnesota Appeals Court Decides Against Honeywell in Mesothelioma Appeal
When mesothelioma victim Ronald Conda filed a lawsuit against those he believed were responsible for his fatal illness, he included Honeywell International and others for exposure outside of his employment in addition to Northern States Power (NSP), his employer. After his death, the jury returned with a verdict that attributed 10% of fault to Honeywell,
-
Epigenetic Therapy Trial Sees Positive Results in Treating Mesothelioma
Malignant mesothelioma, the rare and fatal form of cancer caused by exposure to asbestos, has proven remarkably difficult to treat. It is resistant to the traditional cancer protocols that have worked in other forms of cancer, leaving most patients with a much-reduced quality of life and a survival time of less than two years. In
-
Japanese Mesothelioma Victims Blame Neighborhood Asbestos Plant for Illness
In the last ten years, four different residents of a Tokyo neighborhood have been diagnosed with malignant mesothelioma, and investigators believe that all were sickened by having lived in close proximity to a plant that used asbestos. The victims all lived within 500 meters of a factory that operated until 1980, in a neighborhood known
-
Swiss Facing Realities and Challenges of Mesothelioma
Mesothelioma is a reality that Americans have been dealing with on both medical and legal fronts for over 50 years. In other areas of the world, the awareness of the disease is behind when compared with the U.S., and researchers and legislators alike are only now coming to terms with the actions that need to
-
Baby Powder Mesothelioma Case Ends in Mistrial – Family Will Try Again
After two weeks of testimony, a South Carolina jury was not able to agree on whether Johnson & Johnson’s Baby Powder was responsible for a 30-year-old woman’s malignant mesothelioma, leading to the judge announcing a mistrial. The case follows other trials accusing the company’s talcum powder of having been contaminated with asbestos. In the most
-
Palliative Care Researchers Words Have Special Meaning for Mesothelioma Patients
An award-winning researcher in the field of palliative care spoke recently about the need for greater understanding of what cancer patients go through, and his words had special meaning for those diagnosed with malignant mesothelioma and their loved ones. Dr. Thomas W. LeBlanc, Associate Professor of Medicine at Duke University School of Medicine recently received
-
Mesothelioma Patients Struggle With Cost of Treatment As Much As With Disease
According to recent studies, patients with mesothelioma and other cancers are as overwhelmed with the disease’s impact on their finances as they are with their poor prognosis.
-
Israeli and American Researchers Halt Growth of Mesothelioma
In what may be a game changer in the world of mesothelioma research, an international team from NYU Langone in New York and Technion-Israel Institute of Technology in Haifa announced they successfully halted the growth of malignant mesothelioma in lab animals by inhibiting a specific enzyme.
-
California Woman Wins $21.7 Million Jury Verdict In Mesothelioma Case Against J&J Baby Powder
On the heels of a $117 million New Jersey verdict against Johnson & Johnson, saying asbestos-contaminated talc in their popular baby powder product caused a man’s mesothelioma, a California jury delivered a second stunning verdict against the company. Joanne Anderson, 68, was awarded $21.7 million in compensatory damages by a Los Angeles jury that agreed
-
Promising New Mesothelioma Treatment Shrinks Tumors By 80 to 85% in One Month
A promising new mesothelioma treatment being evaluated by scientists at Italy’s University of Torino has shown remarkable results, with mesothelioma-infected lab animals showing dramatic reduction in the size of their tumors. The non-invasive treatment utilizes a new technology called BNCT, or Boron Neutron Capture Therapy, which has already been used successfully in the treatment of
-
Mesothelioma Victim Wins First Round Against Asbestos Employer
In many legal cases filed by mesothelioma victims, attempting to get justice from the companies responsible for their illness is met with roadblocks. Such was the case of Robert Schindler, who filed a mesothelioma lawsuit against Dravo Basic Materials Company. Schindler worked in the engine room of a vessel called DRAVO in 1973, when the
-
European Researchers Optimistic About Nintedanib’s As Treatment for Pleural Mesothelioma
A new report published in the medical journal “Clinical Cancer Research” is offering a rare dose of encouraging news to those suffering from pleural malignant mesothelioma. According to researchers from leading European universities, the anticancer drug nintedanib is showing extremely promising results in tests of its effectiveness in treating malignant pleural mesothelioma, the rare and
-
New Guidelines Suggest that Mesothelioma Patients Would Benefit From Exercise
Many people think of exercise as nothing but a weight loss tool, and as a result, patients diagnosed with mesothelioma and other types of cancer discount pursuing physical activity, especially in the face of a shortened life span and reduced energy. According to a study in the “Medical Journal of Australia and the Clinical Oncology
